Onorach Innovation

Our innovation focuses on the development of a totally disruptive approach to ensure compliance with regulatory procedures and providing an unparalleled level of trust and transparency.

Onorach Innovation have been working with 12 of the world’s leading pharmaceutical companies for more than three years to find a solution to this problem. Together we have designed a digital eConsent platform which:

• Makes informed consent easy to complete as a patient while ensuring regulatory requirements are met by the sponsor (pharma company), clinical trial sites, principal investigators etc.

• Makes reconsent possible e.g. due to a change in the original clinical trial protocol and informs all stakeholders, including regulatory authorities instantly when reconsent has been obtained.

Onorach Innovation™

Revolutionizing Clinical Trial Participation through Ethical, Scalable, Patient-

Empowering Digital Platforms.

BeeCONSENT™

• Patients overwhelming like the capabilities of the platform and the sense of empowerment over their own data to be used for ethical clinical research purposes.

• Meets or exceeds FDA and EMA regulatory requirements for informed consent to participate in clinical trials.

• Designed in collaboration with 12 of the world's leading pharmaceutical companies and by patient groups representing over 150 million patients.